SBMF Online Payment ▶

test directorySearch Results

Click here to search again.


Test Name:
Haemophilus Influenzae b IgG Antibody


  • SBMF No:
    44096
  • Performance Lab Name:
    ARUP Laboratories
  • Test Mnemonic:
    HIBE IGG
  • ABN:
    Not required
  • CPT Code:
    86317
  • LOINC Code:
    11256-5
  • Ref Lab Test No:
    0050542
  • Also Known As:
    H. Influenzae b IgG Antibody
    Haemophilus influenzae b Vaccine Response
  • Also See:
    45553 Diphtheria, Tetanus, and H. influenzae b IgG Antibodies
  • Spec Type:
    Serum
  • Spec Container:
    Gold top (SST) or red top (serum) tube
  • Pref Vol:
    1.0 mL
  • Min Vol:
    0.15 mL
  • Fasting:
    No
  • Spec Collect:
    Routine venipuncture
  • Spec Process:
    Clot 30 minutes
    Promptly centrifuge 15 minutes
    Immediately transfer serum to separate plastic tube
    Mark specimens clearly as "Pre-Vaccine" or "Post-Vaccine"
  • Spec Store Transport:
    Refrigerated
  • Spec Stability:
    After separation from cells:
    2 days room temperture
    2 weeks refrigerated (2-8°C)
    1 year frozen (-20°C) – Do not use frost-free units that undergo repeated freeze/thaw cycles
  • Spec Reject:
    Plasma or body fluid sample
    Contaminated, hemolyzed or, severely lipemic sample
  • Spec Remarks:
    Separate serum from cells ASAP or within 2 hours of collection
    "Pre" and 30-day "post" Haemophilus influenzae b vaccination specimens should be submitted together for testing.
    "Post" specimen should be drawn 30 days after immunization and must be received within 60 days of "pre" specimen.
  • Methodology:
    Quantitative Multi-Analyte Fluorescence Detection (MAFD)
  • Clinical Significance:
    Refer to:
    ARUP Consult | The Physician's Guide to Laboratory Test Selection and Interpretation
  • Reference Range:

    < 1.0 µg/mL = Antibody concentration not protective.
    ≥ 1.0 µg/mL = Antibody to H. influenzae b detected. Suggestive of protection.

    Interpretive Data:
    Responder status is determined according to the ratio of post-vaccination concentration to pre-vaccination concentration of Haemophilus influenza b antibody, IgG as follows:
    1. If the post-vaccination concentration is less than 3.0 µg/mL, the patient is considered to be a nonresponder.
    2. If the post-vaccination concentration is greater than or equal to 3.0 µg/mL, a patient with a ratio of greater than or equal to 4 is a good responder, a ratio of 2-4 is a weak responder, and a ratio of less than 2 is considered a nonresponder.

  • Day Run:
    Sun-Sat
  • Time Reported:
    2-3 days
  • Test Type:
    INFECTIOUS ANTIBODY